{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fraisinghealth.simplecast.com%2Fepisodes%2Fregulatory-trends-in-telehealth-dVo54KkA","width":444,"version":"1.0","type":"rich","title":"Regulatory Trends in Telehealth","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/8bfdd457-9cd9-4577-bbed-a027587c6960/103ea12d-dd5b-4ef8-b398-ddf54dfbe24e/cover-art-3000x3000-no-grain-2.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/27e9a23f-6be2-4d40-9c1f-31ee3ef07672\" height=\"200\" width=\"100%\" title=\"Regulatory Trends in Telehealth\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Bio + Health deal partner Daisy Wolf joins Sarah Thomas, general counsel at Sameday Health, for a fireside chat on the topic of regulation in telehealth—during Covid and on."}